Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
about
The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected KoreansInitiation of antiretroviral therapy.MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.Renal transplantation in patients with HIV.Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designLiver transplant outcomes in HIV+ haemophilic men.Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast AsiaAntiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.The aging patient with hemophilia.Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.Hemophilia Liver Transplantation Observational Study.Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.Safety and effectiveness of raltegravir in patients with haemophilia and anti-HIV multidrug resistance.
P2860
Q26781379-B55FF113-6EBC-481E-86E0-9FD9CB67D2CFQ30209635-9267A90D-1EB9-4C70-B49E-F80600B2CBC6Q30433644-7E7D217E-0B26-4EF0-8046-065AED8D0606Q33726091-5500ABBC-15DF-428F-AC49-1DB1DD6288F9Q34079397-67958088-BA50-4F59-90D2-57B5E3DA1BBCQ34345002-F5F8775F-46A4-460A-BFD8-C369F79BB6F1Q35150425-825389B3-C998-49A1-9260-FB562236538BQ35153955-0AF71C73-D2D6-4568-B8B0-CC48F3A8980AQ35980818-675DF2ED-083C-4A8B-9631-E0C0F8BC3AE1Q36698602-E5AC53AA-E71D-436F-9062-B4799497ECE6Q37518294-B2CA1EFF-4E7A-4662-BB4E-FCE6DA2E9ABFQ37995101-FACA2F41-D109-44BB-82E8-FF4A7E6A26F4Q38164262-A72D6665-7107-447F-A197-DC43C0ADF504Q39115852-99388FFA-8B23-4BFC-9FE7-6FB9D9058041Q42262381-2F692ABB-19BB-4CA2-86D7-449426112C94Q45871849-DBEFF076-62E3-4A1A-AD63-5FB4574D6CFA
P2860
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@ast
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@en
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@nl
type
label
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@ast
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@en
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@nl
prefLabel
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@ast
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@en
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@nl
P2093
P2860
P1433
P1476
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection
@en
P2093
P2860
P356
10.1111/J.1365-2516.2008.01935.X
P577
2009-03-01T00:00:00Z